I think this article somewhat speaks for itself and why reporting is important and this is probably not the last story we will hear on this. If government had wanted to track this, a data base reporting system could have been set up with applicable laws a long time ago requiring payments to be...
This is probably a good move to speed this process up since many pharmaceutical companies have and are looking at moving more trials to India. More information can be read here about the changing face of Pharma in reference to research and development. One more area to think about too is the use...
Posted to
The Medical Quack .... by Barbara Duck
on 09-19-2008
Filed under: Medically Related, Pharma/FDA News, Genomics, drugs, Pharma, Cancer, clinical trials, Congress, DNA Testing, National Cancer Institute, Justice Department
The issues at hand goes back to 2006 with deviations from specifications on drugs, and now it is up to the Congress and the FDA once more. Did the FDA knowingly allow suspected drugs to continue to be sold? Ranbaxy makes a lot of different generic drugs and there’s no mention of the ones...